Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2023 ∙ Malone, Shelia M. Mitra, Amal K. Onumah, Nwanne A. Brown, Alexis Jones, Lena M. Tresvant, Da'Chirion Brown, Cagney S. Onyia, Austine U. Iseguede, Faith O.
Safety and Efficacy of Post-Eradication Smallpox Vaccine as an Mpox Vaccine: A Systematic Review with Meta-Analysis
Adults Mpox Safety Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Wilson, Lydia Gracie, Lara Kidy, Farah Thomas, G. Neil Nirantharakumar, Krishnarajah Greenfield, Sheila Manaseki-Holland, Semira Ward, Derek J. Gooden, Tiffany E.
Safety and efficacy of tuberculosis vaccine candidates in low- and middle-income countries: a systematic review of randomised controlled clinical trials
Newborn Adolescents Adults Low and Middle Income Countries Tuberculosis Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Hu, Y. Wang, Y. Shao, T. Tang, W. Hu, K. Zhou, Y. Miao, L. Liu, J. Wang, B. Yu, W.
Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes
Adults Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Fan, X. Zhao, Y. Wu, F. Yuan, Y. Lang, B. Yin, D. Xu, Z. Jiang, S. Zou, H. Yuan, J. Sun, C.
Safety and Immunogenicity of SARS-CoV-2 Vaccines in People Living with HIV: A Systematic Review and Meta-analysis of Real-World Studies
Adults Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Kandeel, M. Morsy, M. A. Abd El-Lateef, H. M. Marzok, M. El-Beltagi, H. S. Al Khodair, K. M. Albokhadaim, I. Venugopala, K. N.
Safety and immunogenicity of the ChAdOx1, MVA-MERS-S, and GLS-5300 DNA MERS-CoV vaccines
Adults COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Critically low
2023 ∙ Piché-Renaud, P. P. Yue Lee, E. Ji, C. Qing Huang, J. Y. Uleryk, E. Teoh, C. W. Morris, S. K. Top, K. A. Upton, J. E. M. Vyas, M. V. Allen, U. D.
Safety and immunogenicity of the live-attenuated varicella vaccine in pediatric solid organ transplant recipients: A systematic review and meta-analysis
Newborn Children Adolescents Adults Varicella Safety Efficacy/effectiveness
Rating:
Low
2023 ∙ Stefanou, M. I. Palaiodimou, L. Theodorou, A. Christodoulou, M. V. Tzartos, J. S. Tzanetakos, D. Kitsos, D. Chondrogianni, M. Zouvelou, V. Dardiotis, E. Tzavellas, E. Syrigou, E. Benetou, V. Paraskevas, G. P. Tsiodras, S. Tsivgoulis, G. Giannopoulos, S.
Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Moderate
2023 ∙ Wolfe, D. M. Fell, D. Garritty, C. Hamel, C. Butler, C. Hersi, M. Ahmadzai, N. Rice, D. B. Esmaeilisaraji, L. Michaud, A. Soobiah, C. Ghassemi, M. Khan, P. A. Sinilaite, A. Skidmore, B. Tricco, A. C. Moher, D. Hutton, B.
Safety of influenza vaccination during pregnancy: a systematic review
Pregnant women Influenza Safety
Rating:
High
2023 ∙ van de Pol, N. Pan, Q. Derikx, Laap Bakker, L. van der Woude, C. J. de Vries, A. C.
SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Liang, Y. Sun, Q. Liu, Q. Pang, Y. Tang, S.
SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis
All age groups COVID-19 Coverage
Rating:
Not applicable
Loading...